SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Jubilant Life Sciences informs about analyst meet

14 Dec 2018 Evaluate

Pursuant to the provisions of Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we Jubilant Life Sciences has informed that the management of the company shall be meeting investors/ analysts in Mumbai, India on December 17 and 18, 2018 as part of a Non-Deal Roadshow. The company has also submitted details of investor/ analyst meetings scheduled for the same. The schedule may undergo change due to exigencies on the part of Investors/ Analysts/ Company. Further, the company submits the presentation to be used during the meetings.

The above information is a part of company's filings submitted to BSE.

Jubilant Pharmova Share Price

911.60 6.55 (0.72%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×